dc.contributor.author |
Garbe, Claus |
|
dc.date.accessioned |
2014-03-18T09:45:19Z |
|
dc.date.available |
2014-03-18T09:45:19Z |
|
dc.date.issued |
2012 |
|
dc.identifier.issn |
1471-2598 |
|
dc.identifier.uri |
http://hdl.handle.net/10900/45953 |
|
dc.language.iso |
en |
de_DE |
dc.publisher |
Informa Healthcare |
de_DE |
dc.relation.uri |
http://dx.doi.org/10.1517/14712598.2012.694421 |
de_DE |
dc.rights |
info:eu-repo/semantics/closedAccess |
|
dc.subject.ddc |
570 |
de_DE |
dc.subject.ddc |
610 |
de_DE |
dc.title |
Management of pegylated interferon alpha toxicity in adjuvant therapy of melanoma |
de_DE |
dc.type |
Article |
de_DE |
utue.quellen.id |
20140226071329_01581 |
de_DE |
utue.publikation.seiten |
1087-1099 |
de_DE |
utue.personen.roh |
Daud, Adil |
|
utue.personen.roh |
Soon, Christopher |
|
utue.personen.roh |
Dummer, Reinhard |
|
utue.personen.roh |
Eggermont, Alexander M. M. |
|
utue.personen.roh |
Hwu, Wen-Jen |
|
utue.personen.roh |
Grob, Jean Jacques |
|
utue.personen.roh |
Garbe, Claus |
|
utue.personen.roh |
Hauschild, Axel |
|
dcterms.isPartOf.ZSTitelID |
Expert Opinion on Biological Therapy |
de_DE |
dcterms.isPartOf.ZS-Issue |
8 |
de_DE |
dcterms.isPartOf.ZS-Volume |
12 |
de_DE |
utue.fakultaet |
04 Medizinische Fakultät |
de_DE |